A Phase I/Expansion Study of Dasatinib

Clinical trial NCT00598091 · TERMINATED

Trial details

NCT number: NCT00598091
Sponsor: Duke University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Solid Tumors Pancreatic Adenocarcinoma

Start date: 2007-04-01
Primary completion: 2010-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.